U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"It is my heart-warmed and world-embracing Christmas hope and aspiration that all of us, the high, the low, the rich, the poor, the admired, the despised, the loved, the hated, the civilized, the savage (every man and brother of us all throughout the whole earth), may eventually be gathered together in a heaven of everlasting rest and peace and bliss, except the inventor of the telephone. "

Mark Twain ; Christmas greetings, 1890

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 562/466 - Polycyclo ring system


Subclass of Class 562 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the acid contains two or more carbocyclic
No. of patents: 373
Last issue date: 04/03/2012


1                    
NumberTitleIssue Date
8148572Compounds
The invention relates to substituted phenylacetic acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation. ...
04/03/2012
7495127Potassium channel opener
A potassium channel opener including a compound (e.g., pimaric acid) represented by the formula [I]: wherein R1, R2, R3, R4, R5, R6 and R7 are eac...
02/24/2009
7482484Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia
Disclosed are Compounds of formula I And methods of use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes. ...
01/27/2009
7442808Antidiabetic bicyclic compounds
Tricyclic compounds containing a cyclopropyl carboxylic acid or carboxylic acid derivative (e.g. amide) fused to a bicyclic ring, including pharmaceutically acceptable salts and prodrugs thereof, are agonists of G-protein coupled receptor 40 (GPR40) and are useful a...
10/28/2008
7425644Method of purifying pravastatin
The present invention provides pure pravastatin compositions and pure compactin compositions, and methods for the preparation thereof. ...
09/16/2008
7385083Potassium channel opener
A potassium channel opener comprising a compound (e.g., pimaric acid) represented by the formula [I]: wherein R1, R2, R3, R4, R5, R6
06/10/2008
7321050Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
The present invention provides novel diphenyl ethene compounds and pharmaceutically-acceptable salts thereof. Also provided are methods for making the compounds of the invention as well as methods for the use thereof in the treatment of immune, inflammatory, and aut...
01/22/2008
7304091Statin-like compounds
The present invention relates to compounds with structures resembling natural statins isolated from Penicillium sp. (Formula I); where R1 represents OH, C6H5COO, R6COO and R6 represents C1–C
12/04/2007
7179817Carboxylic acid derivatives and drugs containing the same as the active ingredient
Compounds represented by formula (I), prodrugs thereof and salts thereof, and pharmaceutical compositions comprising the same as an active ingredient (wherein each symbol has the meaning as defined in the specification.). ...
02/20/2007
7160732Fluorescein-based metal sensors, and methods of making and using the same
The present invention is directed, in part, to fluorescein-based ligands for detection of metal ions, and methods of making and using the same. ...
01/09/2007
7148245Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
Compounds of formula (I): in which: Ar represents an aromatic or a heteroaromatic radical optionally substituted, in particular, with an alkyl or a carboxyl group, ...
12/12/2006
7019034Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals
Diabetic mammals are treated with compounds that are significantly more efficacious as agonists of RXRβ retinoid receptors than as agonists of RXRα or RXRγ retinoid receptors. The treatment reduces serum glucose and triglyceride l...
03/28/2006
7019152Process for the optical resolution of a precursor of sclareolide
The present invention relates to the field of organic synthesis and more particularly to a new process for the optical resolution of a precursor of sclareolide. This process includes the reaction of [(1RS,2RS,4aSR,8aSR)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphtha...
03/28/2006
6939988Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
Novel β-aryl-α-oxysubstituted alkylcarboxylic acids of the formula (I) and compositions containing them. The compounds have hypolipidemic, antihyperglycemic uses. ...
09/06/2005
69366365-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity
Compounds of the formula: where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects...
08/30/2005
6924390Surface coating agents
Compounds useful as surface coating agents, including compounds of the formula: wherein X1 comprises a first photoreactive species; X2 comprises a second photoreactive species; Y comprises a nonpo...
08/02/2005
6924388Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
Novel pharmaceutically/cosmetically-active bicyclic aromatic compounds having the structural formula (I): in which Ar1 is a radical having one of the structural formulae (a)-(c):
08/02/2005
6906046Pharmaceutical uses and synthesis of benzobicyclooctanes
Benzobicyclooctane compounds, their use in inhibiting cellular events involving TNF-α and IL-8, and in the treatment of inflammation events in general; a combinatorial library of diverse bicyclooctanes and process for their synthesis as a library and as individual ...
06/14/2005
68878967-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity
Compounds of the formula where the variations have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects of transiently increasin...
05/03/2005
68848205,6,7,8-tetrahydronaphthalen-2-yl-7-fluoroalkyl-heptatrienoic acid derivatives having serum glucose reducing activity
Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effect of reducing serum thyroxin...
04/26/2005
6878842Process for the enantioselective synthesis of propargyl alcohol derivatives of R configuration from the racemic mixtures thereof
The invention relates to a novel process for synthesizing organic compounds of general formula (I): said process may be carried out on an industrial scale and makes it possible to obtain from a...
04/12/2005
6869967Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in th...
03/22/2005
6867320Substituted phenylalkanoic acid derivatives and use thereof
A compound represented by the formula (I) or a salt thereof: wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R1
03/15/2005
6825233Compounds having retinoid-like activity
There are provided compounds represented by the formula I or a nontoxic pharmaceutically acceptable salt, physiologically hydrolyzable ester or solvate thereof, wherein the various substituents are as defined. Also inc...
11/30/2004
6777418Retinoid compounds (I)
The current invention provide novel retinoid compounds and methods for their synthesis, methods of treating or preventing emphysema, cancer and dermatological disorders and pharmaceutical compositions suitable for the treatment or prevention of emphysema, cancer and...
08/17/2004
67595475,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity
Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effect of reducing serum thyroxine ...
07/06/2004
6686386Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis
The present invention relates to pharmaceutical and cosmetic compositions comprising at least one agonist ligand, which is specific for receptors of the RAR-γ type, which are characterized as inducers of apoptosis in at least one cell population in which...
02/03/2004
6683111Compounds, their preparation and use
The present invention relates to compounds of the general formula (I) ##STR1## The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR)....
01/27/2004
6632963Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
Novel pharmaceutically/cosmetically-active bicyclic aromatic compounds have the structural formula (I): ##STR1## in which Ar1 is a radical having one of the structural formulae (a)-(c): ##STR2## Ar2 is a radical having one of th...
10/14/2003
6610877Aromatic carboxylic acid derivatives
Compounds of the formula ##STR1## wherein R1 is a residue of the formula ##STR2## and R2 -R10 have the significance given in the specification can be used as pharmaceuticals, particularly for the repair of photodamaged ...
08/26/2003
6610883Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass...
08/26/2003
6603040Surface coating agents
Compounds useful as surface coating agents, including compounds of the formula: ##STR1## wherein X1 comprises a first photoreactive species; X2 comprises a second photoreactive species; Y comprises a nonpolymeric core molecule c...
08/05/2003
6603012RAR selective retinoid agonists
New compounds containing bicyclic fused rings, one of which being a phenyl moiety connected by an aliphatic chain to a cycloalkyl or aryl moiety, and pharmaceutically active salts thereof are useful as RAR selective retinoid agonists. Furthermore, such re...
08/05/2003
6586463C16 unsaturated FP-selective prostaglandins analogs
Compounds having the general structure: ##STR1## which are useful for the treatment of a variety of diseases and conditions, such as bone disorders....
07/01/2003
6562998Granules of 2-hydroxynaphthalene-3-carboxylic acid and method for preparing the same
Granular product of 2-hydroxynaphthalene-3-carboxylic acid with well-suppressed dusting tendency, and process for preparing the same is provided. Granular product of 2-hydroxynaphthalene-3-carboxylic acid having an average particle size of 150 μm or more...
05/13/2003
6555577Compounds, their preparation and use
The present invention relates to compounds of the general formula (I) ##STR1## The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR)....
04/29/2003
6555704Process for the carbonylation of arylalkyl halides
A method is provided for the preparation of alpha-aryl-propionic acids such as ibuprofen by carbonylating the corresponding 1-arylethyl halide in an acidic aqueous medium containing a palladium catalyst. In the preparation of ibuprofen, 1-(4'-isobutylphen...
04/29/2003
6521646Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
Compounds of the formula (I) and their physiologically acceptable salts and solvates are useful as integrin-inhibiting substances. They are especially useful in the prophylaxis and treatment of cardiovascular disorders, of thrombosis, cardiac infarction, ...
02/18/2003
6495546Propanolamine derivatives
Propanolamine derivatives represented by the following formula (I): ##STR1## These derivatives may be 댣 agonists and exert sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic and anti-urinary incontinence and anti-pollakiuria ac...
12/17/2002
6479549Carnosic acid derivatives for promoting synthesis of nerve growth factor
A novel carnosic acid derivative for promoting the synthesis of nerve growth factor (NGF), a composition comprising the carnosic acid derivative as an effective ingredient, as well as, a method of promoting the synthesis of NGF comprising administering an...
11/12/2002
1                    
 
Sign InRegister
Username  
Password   
forgot password?